A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore: The ACROSS Trial
This study has been completed.
Sponsor:
Nycomed: A Takeda Company
Information provided by (Responsible Party):
Takeda ( Nycomed: A Takeda Company )
ClinicalTrials.gov Identifier:
NCT01313494
First received: March 3, 2011
Last updated: August 18, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2012 |
| Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |